Improvement in Glycemic Response After Bariatric Surgery
NCT ID: NCT05325736
Last Updated: 2025-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2021-07-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement of Insulin Resistance After Bariatric Surgery
NCT03853590
Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls
NCT02563119
Glycemic Index Variations In the Early Period Following Bariatric Surgery
NCT04263168
Improving Diabetes After Bariatric Surgery
NCT00676923
Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome
NCT05363059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies have characterized the microbiome after bariatric surgery, but most suffer from methodological limitations.
The current study has the potential to be innovative and make a significant contribution to understanding the mechanisms involved in early metabolic improvement after bariatric surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sleeve gastrectomy surgery
participants undergoing sleeve gastrectomy surgery for weight reduction
sleeve gastrectomy surgery
participants undergoing sleeve gastrectomy surgery
gastric bypass surgery
participants undergoing gastric bypass surgery for weight reduction
gastric bypass surgery
participants undergoing gastric bypass surgery
cholecystectomy
participants undergoing cholecystectomy
control
cholecystectomy
Pancreatectomy
participants undergoing Pancreatectomy
Pancreatectomy
Collecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleeve gastrectomy surgery
participants undergoing sleeve gastrectomy surgery
gastric bypass surgery
participants undergoing gastric bypass surgery
control
cholecystectomy
Pancreatectomy
Collecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-70
* male/female
Exclusion Criteria
* type 1 diabetes
* antibiotic treatment 3 months prior to the study
* probiotic treatment 3 months prior to the study
* chronic disease - gastrointestinal disease, malignancy, psychiatric disorder, endocrinologic disorders
* any pathologic findings during endoscopy
* participants who will suffer from a post-operation complication
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Weizmann Institute of Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avner Leshem, MD
Role: STUDY_DIRECTOR
Weizmann institute
Danit Dayan, MD
Role: PRINCIPAL_INVESTIGATOR
Souraski medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weizmann Institute of Science
Rehovot, , Israel
Souraski medical center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Avner Leshem, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0046-21-TLV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.